• search hit 5 of 5
Back to Result List

Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients

  • Chronic non-cancer pain (CNCP) is a major health problem. Patients are increasingly treated with chronic opioid therapy (COT). Several laboratory studies have demonstrated that long-term use of opioids does not generally impair driving related skills. But there is still a lack of studies investigating on-the-road driving performance in actual traffic. The present study assessed the impact of COT on road-tracking and car-following performance in CNCP patients. Twenty CNCP patients, long-term treated with stable doses of opioid analgesics, and 19 healthy controls conducted standardized on-the-road driving tests in normal traffic. Performance of controls with a blood alcohol concentration (BAC) of 0.5 g/L was used as a reference to define clinically relevant changes in driving performance. Standard Deviation of Lateral Position (SDLP), a measure of road-tracking control, was 2.57 cm greater in CNCP patients than in sober controls. This difference failed to reach statistical significance in a superiority test. Equivalence testing indicated that the 95% CI around the mean SDLP change was equivalent to the SDLP change seen in controls with a BAC of 0.5 g/L and did not include zero. When corrected for age differences between groups the 95% CI widened to include both the alcohol reference criterion and zero. No difference was found in car-following performance. Driving performance of CNCP patients did not significantly differ from that of controls due to large inter-individual variations. Hence in clinical practice determination of fitness to drive of CNCP patients who receive opioid treatments should be based on an individual assessment.

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Markus B. Schumacher, Stefan Jongen, Anja Knoche, Frank Petzke, Eric F. Vuurman, Mark Vollrath, Johannes G. Ramaekers
Document Type:Article
Language:English
Date of Publication (online):2018/09/11
Contributing corporation:Maastricht University. Department of Neuropsychology and Psychopharmacology
Release Date:2018/09/11
Tag:Arzneimittel; Droge; Fahrtauglichkeit; Fahrzeugführung; Medizinische Gesichtspunkte; Sicherheit
Driving (veh); Driving aptitude; Drugs; Medical aspects; Medication; Safety
Comment:
Außerdem beteiligt: Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen ; Technische Universität Braunschweig, Institut für Psychologie, Ingenieur- und Verkehrspsychologie

Volltext frei verfügbar unter: doi.org/10.1007/s00213-017-4539-3
Source:Psychopharmacology 234 (2017), 6, S. 989-99
Institutes:Abteilung Verhalten und Sicherheit im Verkehr / Abteilung Verhalten und Sicherheit im Verkehr
Sonstige / Sonstige
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
collections:BASt-Beiträge / ITRD Sachgebiete / 83 Unfall und Mensch

$Rev: 13581 $